dvm360 expands portfolio with addition of Atlantic Coast Veterinary Conference

Publication
Article
dvm360dvm360 May 2019
Volume 50
Issue 5
Atlantic City

ACVC follows MJH Associates recent acquisition of media assets from UBM Life Sciences Group.

MJH Associates Inc. (MJH)-a leading independent full-service healthcare education, market research and multichannel medical communications company-recently acquired media assets from the UBM Life Sciences Group (part of Informa plc and, before that, UBM plc), including its market-leading dvm360 brands: dvm360.com, dvm360 magazine, Vetted, Firstline and the Fetch dvm360 conferences. With this acquisition, dvm360 is now part of the MultiMedia Healthcare Group and will add the Atlantic Coast Veterinary Conference (ACVC) to its portfolio.

“We are excited to add the Atlantic Coast Veterinary Conference to our Rolodex of leading educational veterinary conferences across the country. We look forward to using American Veterinarian's assets along with ours to continue to excel this conference further,” says Tom Ehardt, president of MultiMedia Healthcare Group.

In the veterinary space, the dvm360 group plans to blend American Veterinarian assets into its portfolio by leveraging key strengths to support dvm360's No. 1 readership and engagement position. This follows with the addition of the Atlantic Coast Veterinary Conference to the list of premier conferences. ACVC will take place Oct. 14-17 at the Atlantic City Convention Center in New Jersey.

ACVC, now in its 30th year, is a four-day educational event that offers over 200 hours of Registry of Approved Continuing Education-approved veterinary continuing education. The conference will also offer educational tracks tailored for technicians, practice managers and front office staff. Attendees will have access to more than 200 exhibitors and many opportunities to network and collaborate with their peers.

For more information and to register for the early bird special, visit acvc.org.

Related Videos
NAVC Gives
NAVC CEO Gene O'Neill
© 2024 MJH Life Sciences

All rights reserved.